Search Within

Jae Hong Park

Formats
  1. Meeting Abstract (222)
  2. Journal Article (132)
  3. Review (18)
  4. Research Letter (7)
  5. Editorial (3)
  6. Guidelines (3)
  7. Book Section (2)
  8. Correspondence (2)
Groups
  1. Adult Leukemia (389)
  2. Center for Hematologic Malignancies (389)
  3. Department of Medicine (389)
  4. Hematologic Malignancies, Division of (389)
  5. GSK Faculty (188)
  6. Hematology-Oncology Fellows (157)

More Groups

People
  1. Renier Brentjens (105)
  2. Isabelle Riviere (85)
  3. Maria Palomba (85)
  4. Michel Sadelain (84)
  5. Martin Tallman (81)
  6. Miguel-Angel Perales (73)

More People

Years
  1. 2025 (37)
  2. 2024 (38)
  3. 2023 (38)
  4. 2022 (34)
  5. 2021 (29)
  6. 2020 (24)

More Years

Publications
  1. Blood (148)
  2. Journal of Clinical Oncology (31)
  3. Blood Advances (15)
  4. British Journal of Haematology (9)
  5. Haematologica (9)
  6. Leukemia and Lymphoma (9)

More Publications

Publishers
  1. American Society of Hematology (163)
  2. Elsevier Inc. (35)
  3. American Society of Clinical Oncology (33)
  4. Nature Publishing Group (32)
  5. Taylor & Francis Group (12)
  6. American Association for Cancer Research (10)

More Publishers

Results (389)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma
    Journal Article

    Winkelmann, M.; Raj, S. S.; Jain, M. D.; Iacoboni, G.; Müller, F.; Hansmann, L.; Corona, M.; Luna, A.; Jhaveri, K.; Shah, G. L.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Pre-infusion risk factors predict severe infectious complications of CAR T-cell therapy in pediatric and adult patients with B-ALL
    Journal Article

    Culbert, A. A.; Gava, F.; Valtis, Y. K.; Satta, T.; Vora, S.; Rocco, J. M.; Nussenblatt, V.; Silbert, S. K.; Shalabi, H.; Yates, B.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Haematotoxicity risk factors for sub-optimal outcomes following obecabtagene autoleucel for relapsed/refractory B-cell acute lymphoblastic leukaemia
    Meeting Abstract

    Roddie, C.; Park, J. H.; Shaughnessy, P.; Logan, A. C.; Sandhu, K. S.; Abedi, M.; Shah, B. D.; Bishop, M. R.; DeAngelo, D. J.; Tholouli, E.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Tumour burden-guided dosing in the FELIX study of obecabtagene autoleucel in adult R/R B-ALL
    Meeting Abstract

    Yallop, D.; Jabbour, E.; Sandhu, K. S.; Shaughnessy, P.; Logan, A. C.; Abedi, M.; Shah, B. D.; Bishop, M. R.; Park, J. H.; DeAngelo, D. J.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Obecabtagene autoleucel with/without consolidative stem cell transplantation in relapsed/refractory B-cell acute lymphoblastic leukaemia: Patient outcomes
    Meeting Abstract

    Tholouli, E.; Park, J. H.; Jabbour, E.; Shah, B. D.; Shaughnessy, P.; Logan, A. C.; Sandhu, K. S.; Abedi, M.; Bishop, M. R.; DeAngelo, D. J.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Depth of MRD-negative remission and outcomes in adults with R/R B-ALL treated with obecabtagene autoleucel
    Meeting Abstract

    Roddie, C.; Park, J. H.; Shaughnessy, P.; Logan, A. C.; Sandhu, K. S.; Abedi, M.; Shah, B. D.; Bishop, M. R.; DeAngelo, D. J.; Tholouli, E.; more...
    British Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Real-world evaluation of user engagement with an artificial intelligence-powered clinical trial application in oncology
    Journal Article

    Hung, T. K. W.; Mao, J. J.; Ho, A. L.; Sherman, E. J.; Robson, M.; Park, J.; Stein, E. M.; Kuperman, G. J.; Pfister, D. G.
    Journal of the American Medical Informatics Association (2025)

    Fulltext@MSK | Save
  • The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia
    Journal Article

    O'Connor, T. E.; Lin, C.; Roloff, G. W.; Zhang, A.; Miller, K.; Aldoss, I.; Kopmar, N. E.; Dekker, S. E.; Gupta, V. K.; Jeyakumar, N.; more...
    Bone Marrow Transplantation (2025)

    Fulltext@MSK | Save
  • Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement
    Journal Article

    Muhsen, I. N.; Roloff, G. W.; Faramand, R.; Othman, T.; Valtis, Y.; Kopmar, N. E.; Dekker, S. E.; Connor, M.; Mercadal, S.; O'Connor, T. E.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Advancing the management of CH, MDS, and AML from the first Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference
    Editorial

    Carraway, H. E.; Brunner, A. M.; Lai, C. E.; Luskin, M. R.; Park, J.; Perl, A. E.; Stein, E. M.; Wang, E. S.; Zeidan, A. M.; Zeidner, J. F.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2025)

    Fulltext@MSK | Save